Osama Mosalem

5PUBLICATIONS
11CO-AUTHORS
Molecular targetsPredictive and prognostic markersChemotherapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 26, 2025
Pancreatic ductal adenocarcinoma (PDAC): clinical progress in the last five years.

Osama M Mosalem, Ahmed Abdelhakeem, Nayef H Abdel-Razeq

|May 22, 2024
A comprehensive analysis of POLE/POLD1 genomic alterations in colorectal cancer.

Osama Mosalem, Tucker W Coston, Robin Imperial

|Apr 23, 2024
Second-Line Treatment of Pancreatic Adenocarcinoma: Shedding Light on New Opportunities and Key Talking Points from Clinical Trials.

Robin Imperial, Osama Mosalem, Umair Majeed

|Feb 10, 2024
A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysis.

Osama Mosalem, Winston Tan, Alan H Bryce

|Jan 29, 2024
Severe Cytokine Release Syndrome and Hemophagocytic Lymphohistiocytosis (HLH)-Like Syndrome Following Administration of Combined Brentuximab Vedotin and Nivolumab for Recurrent Classical Hodgkin Lymphoma: A Case Report.

Osama Mosalem, Tanmayi Pai, Mohammed Alqawasma

Pageof 1

Frequent Collaborators

1 joint publications

Ahmed Abdelhakeem

1 joint publications

Tanmayi Pai

1 joint publications

Muhamad Alhaj Moustafa

1 joint publications

Alan H Bryce